...
首页> 外文期刊>Bioanalysis >Molecularly imprinted SPE combined with dispersive liquid-liquid microextraction for selective analysis of telmisartan in biological and formulation samples
【24h】

Molecularly imprinted SPE combined with dispersive liquid-liquid microextraction for selective analysis of telmisartan in biological and formulation samples

机译:分子印迹SPE与分散液-液微萃取相结合用于生物和制剂样品中替米沙坦的选择性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The present communication describes the combination of molecularly imprinted SPE and dispersive liquid-liquid microextraction for the selective preconcentration and determination of telmisartan (TEL) in rat urine, plasma and pharmaceutical formulation by HPLC. Results: Various factors that can affect the extraction efficiency of molecularly imprinted SPE and dispersive liquid-liquid microextraction were optimized. The LOD and LOQ were found to be 0.19 and 0.63 g ml-1 in urine, while in plasma it was found to be 0.28 and 0.87 g ml-1, respectively. The percentage recovery of TEL in different matrices was found to be in the range of 81-97%. Conclusion: The proposed method may find wide applications in clinical, toxicological and QC laboratories for the routine analysis of TEL.
机译:背景:本来文描述了分子印迹固相萃取和分散液-液微萃取的组合,用于通过HPLC选择性预浓缩和测定大鼠尿液,血浆和药物制剂中的替米沙坦(TEL)。结果:优化了影响分子印迹固相萃取和分散液-液微萃取的各种因素。发现尿中的LOD和LOQ为0.19 g / ml-1和0.63 g ml-1,而血浆中的LOD和LOQ分别为0.28和0.87 g ml-1。发现不同基质中TEL的回收百分比在81-97%的范围内。结论:该方法可在临床,毒理学和质量控制实验室中广泛应用于电话常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号